BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35338724)

  • 1. Safety and efficacy of rapid drug desensitization in children.
    Esenboga S; Akarsu A; Ocak M; Gur Cetinkaya P; Sahiner UM; Sekerel BE; Soyer O
    Pediatr Allergy Immunol; 2022 Mar; 33(3):e13759. PubMed ID: 35338724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
    Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
    Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
    Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
    Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
    World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.
    Caiado J; Castells MC
    Curr Allergy Asthma Rep; 2021 Jul; 21(6):37. PubMed ID: 34232411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
    Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
    Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies.
    Sloane D; Govindarajulu U; Harrow-Mortelliti J; Barry W; Hsu FI; Hong D; Laidlaw T; Palis R; Legere H; Bunyavanich S; Breslow R; Wesemann D; Barrett N; Brennan P; Chong HJ; Liu A; Fernandez J; Fanning L; Kyin T; Cahill K; Bankova L; Lynch A; Berlin S; Campos S; Fuchs C; Mayer R; Matulonis U; Castells M
    J Allergy Clin Immunol Pract; 2016; 4(3):497-504. PubMed ID: 26895621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors.
    Caiado J; Brás R; Paulino M; Costa L; Castells M
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):325-333.e1. PubMed ID: 32353405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Dilution Rapid Desensitization Protocol to Chemotherapeutic and Biological Agents: A Five-Year Experience.
    Sala-Cunill A; Molina-Molina GJ; Verdesoto JT; Labrador-Horrillo M; Luengo O; Galvan-Blasco P; Guilarte M; Cardona V
    J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4045-4054. PubMed ID: 34214705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin-induced hypersensitivity reactions: risk factors and management.
    Selcuk A; Yıldız B
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2640-2645. PubMed ID: 37013782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.
    Madrigal-Burgaleta R; Bernal-Rubio L; Berges-Gimeno MP; Carpio-Escalona LV; Gehlhaar P; Alvarez-Cuesta E
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):618-632. PubMed ID: 30098410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity.
    Alonso Martinez S; Segal NH; Cercek A; Yaeger R; Stadler Z; Kemeny NE; Nusrat M; Shahrokni A; Connell L; Saltz LB
    Clin Colorectal Cancer; 2022 Jun; 21(2):149-153. PubMed ID: 35125319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.
    Castells M; Sancho-Serra Mdel C; Simarro M
    Cancer Immunol Immunother; 2012 Sep; 61(9):1575-84. PubMed ID: 22576054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.